Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3716560 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1163684 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL9238670 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL94566 | 0.90 | — | — | |
| SCHEMBL5168783 | 0.79 | TSHR (0.67) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL13855529 | 0.79 | TSHR (0.67) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL7687851 | 0.79 | TSHR (0.67) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL20475058 | 0.79 | TSHR (0.67) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL7693275 | 0.79 | TSHR (0.67) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1163681 | 0.79 | TSHR (0.67) | TSHRLMNANFKB1PMP22GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230204570-A1 | SENSOR DEVICE FOR ELECTROCHEMICAL ANALYSIS OF BIOLOGICAL SAMPLES | FOOTHOLD LABS INC. | 2023-06-29 | — | — | US | disclosed |
| US-10829861-B2 | Reduction catalyst, and chemical reactor, reduction method and reduction product-producing system employing the catalyst | KABUSHIKI KAISHA TOSHIBA (JP) | 2020-11-10 | — | — | US | disclosed |
| US-10550488-B2 | Reduction catalyst, reduction reactor and reduction method | KABUSHIKI KAISHA TOSHIBA (JP) | 2020-02-04 | — | — | US | disclosed |
| EP-3354338-B1 | REDUCTION CATALYST, CHEMICAL REACTOR, REDUCTION METHOD AND REDUCTION PRODUCT-PRODUCING SYSTEM EMPLOYING THE CATALYST | TOSHIBA KK (JP) | 2019-10-02 | — | — | EP | disclosed |
| US-10366799-B2 | Transparent conductor, method for preparing the same and display apparatus including the same | SAMSUNG SDI CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-10308574-B2 | Reduction catalyst and chemical reactor | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-06-04 | — | — | US | disclosed |
| US-10301724-B2 | Electrochemical reaction device | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-05-28 | — | — | US | disclosed |
| US-10196748-B2 | Reduction catalyst and chemical reactor | KABUSHIKI KAISHA TOSHIBA (JP) | 2019-02-05 | — | — | US | disclosed |
| EP-3006604-B1 | REDUCTION CATALYST AND CHEMICAL REACTOR | TOSHIBA KK (JP) | 2018-12-12 | — | — | EP | disclosed |
| EP-3354338-A1 | REDUCTION CATALYST, AND CHEMICAL REACTOR, REDUCTION METHOD AND REDUCTION PRODUCT-PRODUCING SYSTEM EMPLOYING THE CATALYST | KABUSHIKI KAISHA TOSHIBA (JP) | 2018-08-01 | — | — | EP | disclosed |
| US-20170154698-A1 | TRANSPARENT CONDUCTOR, METHOD FOR PREPARING THE SAME AND DISPLAY APPARATUS INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2017-06-01 | — | — | US | disclosed |
| EP-3006604-A1 | REDUCTION CATALYST AND CHEMICAL REACTOR | Kabushiki Kaisha Toshiba, Inc. (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-20160076158-A1 | REDUCTION CATALYST AND CHEMICAL REACTOR | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-03-17 | — | — | US | disclosed |
| CN-105247108-A | Reduction catalyst and chemical reactor | TOSHIBA KK | 2016-01-13 | — | — | CN | disclosed |
| US-20150036276-A1 | TRANSPARENT CONDUCTIVE FILM, CONDUCTIVE ELEMENT, COMPOSITION, COLORED SELF-ASSEMBLED MATERIAL, INPUT DEVICE, DISPLAY DEVICE, AND ELECTRONIC INSTRUMENT | DEXERIALS CORPORATION (JP) | 2015-02-05 | — | — | US | disclosed |
| CN-104145312-A | Transparent conductive film, conductive element, composition, colored self-organizing material, input device, display device, and electronic device | DEXERIALS CORP | 2014-11-12 | — | — | CN | disclosed |
| US-20110091974-A1 | Conductive Substrate and Method for Introducing Nucleic Acid | KYOTO UNIVERSITY (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-2113565-A1 | CONDUCTIVE SUBSTRATE FOR NUCLEIC ACID DELIVERY AND METHOD FOR DELIVERING NUCLEIC ACID | Kyoto University (JP) | 2009-11-04 | — | — | EP | disclosed |
| EP-1842554-A1 | COATED MAGNETIC PARTICLE CONTAINING PREPARATION, PROCESS FOR PRODUCING THE SAME AND DIAGNOSTIC THERAPEUTIC SYSTEM | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-10-10 | — | — | EP | disclosed |
| US-20060171894-A1 | Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308574-B2 | Reduction catalyst and chemical reactor | MPO, NOX4, IDH2 | TSHR 3892/4885LMNA 3866/4885NFKB1 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.